Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock
VHAQ.U
VHAQ.U was delisted on the 21st of February, 2024.
15 hedge funds and large institutions have $6.92M invested in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
17% less funds holding
Funds holding: 18 → 15 (-3)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
55% less capital invested
Capital invested by funds: $15.5M → $6.92M (-$8.57M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$115K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$47.6K |
| 3 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$43.7K |
| 4 |
HF
HRT Financial
New York
|
+$12.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$5.15M |
| 2 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
-$1.84M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
-$1.81M |
| 4 |
Walleye Capital
New York
|
-$46.9K |
| 5 |
Walleye Trading
New York
|
-$31.2K |
VHAQ.U Hedge Fund Activity: Q2 2021 in Review
15 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) for Q2 2021, worth a combined $6.92M — down 55% from $15.5M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of VHAQ.U and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $115K. The largest seller was Aristeia Capital, exiting entirely with an estimated $5.15M sold.
- 15 institutional investors held Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) as of Q2 2021, down from 18 in Q1 2021.
- Funds reported $6.92M of Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock stock for Q2 2021, down 55% quarter-over-quarter.
- 1 fund opened new Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock positions in Q2 2021 and 4 closed out, a net change of -3 holders.
- The largest Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock buyer in Q2 2021 was Citadel Advisors, an estimated $115K added.
- The largest Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock seller in Q2 2021 was Aristeia Capital, an estimated $5.15M sold.
Based on aggregated 13F filings for Q2 2021.